质母细胞瘤中的生物标志物概要:过去和现在
Ligia Gabriela Tataranu1,2, Serban Turliuc3, Radu Eugen Rizea1,2
1Neurosurgical Department, University of Medicine and Pharmacy "Carol Davila", 020022 Bucharest, Romania.
Current issues in molecular biology
|July 26, 2024
概括
质母细胞瘤是一种常见的恶性脑瘤,仍然无法治愈,但呈现出进展. 神经外科的进步和对质母细胞瘤生物标志物的理解改善了患者的预后和治疗策略.
科学领域:
- 神经瘤学神经瘤学
- 神经外科 神经外科
- 分子生物学分子生物学
背景情况:
- 质母细胞瘤占成人恶性脑瘤的48%,由于其不可治愈的性质和高发病率,它带来了重大挑战.
- 尽管神经外科技术的进步使瘤切除更安全,但质母细胞瘤仍然是一个难以治疗的癌症.
研究的目的:
- 审查最近在质母细胞瘤的手术和分子管理方面的进展.
- 突出生物分子进步对理解质母细胞瘤及其治疗策略的影响.
主要方法:
- 审查当前的多式疗法方法,包括神经外科手术,放射治疗和化疗 (temozolomide).
- 对质母细胞瘤生物标志物的最新发现进行分析,以预测预后和治疗反应.
主要成果:
- 神经外科的进步提高了安全切除瘤的程度.
- 生物分子研究已经确定了质母细胞瘤的潜在新治疗点和预测生物标志物.
- 尽管有治疗耐药性和复发,但生物标志物改善了生存率和管理.
结论:
- 虽然质母细胞瘤缺乏治愈方法,但结合手术和分子方法正在改善患者的治疗结果.
- 对质母细胞瘤生物标志物的持续研究对于开发更有效和个性化的治疗策略至关重要.
更多相关视频
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.8K
09:17Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
2.3K
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...